Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5. [electronic resource]
Producer: 20070531Description: 2159-67 p. digitalISSN:- 1524-4539
- 3',5'-Cyclic-GMP Phosphodiesterases -- antagonists & inhibitors
- Animals
- Atrial Natriuretic Factor -- pharmacology
- Cell Compartmentation -- physiology
- Cell Membrane -- enzymology
- Cells, Cultured -- drug effects
- Cyclic GMP -- physiology
- Cyclic GMP-Dependent Protein Kinases -- antagonists & inhibitors
- Cyclic Nucleotide Phosphodiesterases, Type 5
- Cytosol -- enzymology
- Enzyme Activation -- drug effects
- Guanylate Cyclase -- metabolism
- Isoproterenol -- pharmacology
- Male
- Mice
- Mice, Inbred C57BL
- Myocardial Contraction -- drug effects
- Myocytes, Cardiac -- drug effects
- NG-Nitroarginine Methyl Ester -- pharmacology
- Nitric Oxide -- physiology
- Phosphodiesterase Inhibitors -- pharmacology
- Piperazines -- pharmacology
- Protein Kinase Inhibitors -- pharmacology
- Purines -- pharmacology
- Receptors, Adrenergic, beta -- drug effects
- Second Messenger Systems -- physiology
- Sildenafil Citrate
- Sulfones -- pharmacology
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.